Additionally, autoantibody-mediated impairment of DNASE1L3 activity has recently been identified as a common nongenetic mechanism facilitating the development of anti-dsDNA Abs in patients with severe sporadic SLE (8, 20). Here, DNASE1L3 is linked to systemic lupus erythematosus.